Interestingly, in MM, inhibition of TGFβ1 could counteract the growth advantages conferred by the adherence of MM cells to bone marrow stromal cells, as well as cytokine production in the bone marrow microenvironment, and enhance the host’s anti-MM immunity (61). This evidence concerns the gene TGFB1 and Miyoshi myopathy.